Serum HE4 as a prognostic marker in endometrial cancer — A population based study

HE4 has emerged as a promising biomarker in gynaecological oncology. The purpose of this study was to evaluate serum HE4 as a biomarker for high-risk phenotypes in a population-based endometrial cancer cohort. Peri-operative serum HE4 and CA125 were measured in 373 patients identified from the prosp...

Full description

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 2014-01, Vol.132 (1), p.159-165
Main Authors: Brennan, Donal J., Hackethal, Andreas, Metcalf, Alex M., Coward, Jermaine, Ferguson, Kaltin, Oehler, Martin K., Quinn, Michael A., Janda, Monika, Leung, Yee, Freemantle, Michael, Webb, Penelope M., Spurdle, Amanda B., Obermair, Andreas
Format: Article
Language:English
Subjects:
Biomarker
Biomarkers, Tumor - blood
CA-125 Antigen - blood
Endometrial cancer
Endometrial Neoplasms - blood
Endometrial Neoplasms - mortality
Endometrial Neoplasms - pathology
Female
HE4
Hematology, Oncology and Palliative Medicine
Humans
Middle Aged
Neoplasm Staging
Obstetrics and Gynecology
Prognosis
Prognostic marker
Proportional Hazards Models
Proteins - analysis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!